Aslihan Shenol Iliyaz

Aslihan Shenol Iliyaz

PhD Student, Research Assistant

Member of:

    ORCID: 0000-0003-2508-3335

    Publication year:
    All
    1 - 4 out of 4Page size: 10
    1. 2024
    2. Published

      Molecular dynamics-based identification of binding pathways and two distinct high-affinity sites for succinate in succinate receptor 1/GPR91

      Iliyaz, Aslihan Shenol, Lückmann, Michael, Trauelsen, Mette, Lambrughi, M., Tiberti, M., Papaleo, E., Frimurer, Thomas Michael & Schwartz, Thue W., 2024, In: Molecular Cell. 84, 5, p. 955-966.e4 17 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. 2022
    4. Published

      Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action

      Lückmann, Michael, Iliyaz, Aslihan Shenol, Nissen, T. A. D., Petersen, Jacob Emil, Kouvchinov, David, Schwartz, Thue W. & Frimurer, Thomas Michael, 2022, In: ACS Medicinal Chemistry Letters. 13, 12, p. 1839-1847

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. 2021
    6. Published

      Molecular mechanism of ligand binding pathways and activation of the succinate receptor

      Iliyaz, Aslihan Shenol, Lückmann, Michael, Trauelsen, Mette, Frimurer, Thomas Michael & Schwartz, Thue W., 2021, In: European Biophysics Journal. 50, Suppl. 1, p. 160 1 p., P-234.

      Research output: Contribution to journal › Conference abstract in journal › Research

    7. 2019

    8. Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model

      Yoncheva, K., Merino, M., Iliyaz, Aslihan Shenol, Daskalov, N. T., Petkov, P. S., Vayssilov, G. N. & Garrido, M. J., 10 Feb 2019, In: International Journal of Pharmaceutics. 556, p. 1-8 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 226572983